Raymond James Trust’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.96M | Buy |
3,879
+1,561
| +67% | +$789K | 0.04% | 327 |
|
|
2024
Q2 | $1.13M | Sell |
2,318
-46
| -2% | -$22.4K | 0.03% | 441 |
|
|
2024
Q1 | $1.28M | Buy |
2,364
+9
| +0.4% | +$4.86K | 0.03% | 407 |
|
|
2023
Q4 | $1.31M | Buy |
2,355
+288
| +14% | +$160K | 0.03% | 389 |
|
|
2023
Q3 | $904K | Buy |
2,067
+4
| +0.2% | +$1.75K | 0.03% | 447 |
|
|
2023
Q2 | $1.04M | Sell |
2,063
-36
| -2% | -$18.1K | 0.03% | 424 |
|
|
2023
Q1 | $1.05M | Buy |
2,099
+415
| +25% | +$208K | 0.03% | 403 |
|
|
2022
Q4 | $687K | Sell |
1,684
-460
| -21% | -$188K | 0.02% | 498 |
|
|
2022
Q3 | $699K | Buy |
2,144
+420
| +24% | +$137K | 0.03% | 464 |
|
|
2022
Q2 | $605K | Buy |
1,724
+100
| +6% | +$35.1K | 0.02% | 526 |
|
|
2022
Q1 | $888K | Buy |
1,624
+343
| +27% | +$188K | 0.03% | 448 |
|
|
2021
Q4 | $843K | Buy |
1,281
+150
| +13% | +$98.7K | 0.03% | 474 |
|
|
2021
Q3 | $703K | Sell |
1,131
-194
| -15% | -$121K | 0.02% | 498 |
|
|
2021
Q2 | $837K | Sell |
1,325
-61
| -4% | -$38.5K | 0.03% | 444 |
|
|
2021
Q1 | $678K | Buy |
1,386
+734
| +113% | +$359K | 0.02% | 473 |
|
|
2020
Q4 | $326K | Buy |
+652
| New | +$326K | 0.01% | 730 |
|
|
2019
Q4 | – | Sell |
-752
| Closed | -$204K | – | 974 |
|
|
2019
Q3 | $204K | Buy |
+752
| New | +$204K | 0.01% | 851 |
|
|
2016
Q3 | – | Sell |
-4,322
| Closed | -$402K | – | 690 |
|
|
2016
Q2 | $402K | Sell |
4,322
-505
| -10% | -$47K | 0.04% | 383 |
|
|
2016
Q1 | $378K | Buy |
4,827
+1,388
| +40% | +$109K | 0.04% | 393 |
|
|
2015
Q4 | $250K | Buy |
+3,439
| New | +$250K | 0.02% | 529 |
|